Skip to content
PH-RO19

Breast tumours

How breast carcinoma arises from luminal cells of the lobule, why DCIS and lobular neoplasia precede ductal and lobular invasion, what oestrogen receptor, PR and HER2 status say about its biology, and how it spreads.

  • Free preview
  • 5 steps · 9 questions
  • 3D anatomy, affected parts marked

By the end, you can

  • Relate the cells of the breast to its benign, in situ and invasive tumours, and name the main types in current terminology.
  • Explain how lifetime oestrogen exposure and inherited BRCA1 or BRCA2 variants raise the risk of breast carcinoma.
  • Contrast DCIS with lobular neoplasia, and invasive carcinoma of no special type with invasive lobular carcinoma, linking E-cadherin loss to single-file growth.
  • Describe oestrogen receptor, progesterone receptor and HER2 status as biology, as the basis of the molecular subtypes and as predictive factors.
  • Explain how breast carcinoma spreads, what grade and stage measure, and why it causes skin dimpling, nipple retraction and orange-peel skin.

What it is

Breast tumours arise from the epithelium of the terminal duct lobular unit or, less often, its stroma. Almost all malignant ones are carcinomas of the luminal epithelium: confined within ducts and lobules as carcinoma in situ, or invasive once they cross the basement membrane. Invasive carcinoma is classified by its pattern (no special type, lobular, special types) and by its oestrogen receptor (ER), progesterone receptor (PR) and HER2 status.

6 types to tell apart
Ductal carcinoma in situ (DCIS)
Malignant, clonal luminal cells filling and distending ducts within an intact basement membrane; graded low, intermediate or high; a non-obligate precursor of invasive carcinoma.
Lobular neoplasia (ALH and LCIS)
Small, discohesive cells without E-cadherin filling lobular acini; usually found by chance, a marker of risk in both breasts and a non-obligate precursor of lobular carcinoma.
Invasive carcinoma of no special type (NST)
The commonest invasive type, about three-quarters of cases; formerly called invasive ductal carcinoma. Nests, cords and glands in a dense fibrous stroma.
Invasive lobular carcinoma
About a tenth of cases: E-cadherin-negative cells infiltrating singly and in single file, often forming no discrete mass; usually ER positive.
Special types
Tubular and mucinous carcinomas, usually low grade with a favourable course; metaplastic carcinoma, usually triple negative and aggressive; NST with medullary pattern, rich in lymphocytes.
Non-epithelial tumours
Malignant phyllodes tumour, angiosarcoma (rare, sometimes years after radiotherapy) and lymphoma; they behave like their counterparts elsewhere.

US spelling: tumours → tumors, oestrogen → estrogen.

Normal function

The cells of the breast and the signals they obey

The of the breast drain through to the . Their working units are terminal duct lobular units, lined by inner luminal cells and outer myoepithelial cells on a basement membrane, in a hormone-responsive stroma (the benign changes lesson covers them in detail).

Some luminal cells carry the oestrogen receptor (ER), a nuclear receptor: oestrogen binds it and it switches on growth genes, including the gene for the progesterone receptor (PR), so PR expression shows a working ER pathway. HER2 is a membrane tyrosine kinase receptor of the EGFR family; normal cells carry few copies, and it signals only by pairing with its partners. BRCA1 and BRCA2 repair DNA double-strand breaks accurately by homologous recombination.

About three-quarters of the lymph from the breast drains to the axillary lymph nodes, along the of the gland towards the armpit; the rest goes mainly to nodes beside the sternum.

Point to it on the model
Cells of the breast and their tumoursSchematic
FeatureBenign or risk lesionIn situInvasive
Ductal (luminal) epitheliumUsual and atypical ductal hyperplasiaDCISInvasive carcinoma NST
Lobular epitheliumAtypical lobular hyperplasiaLobular carcinoma in situInvasive lobular carcinoma
Special patternsNot applicableNot applicableTubular, mucinous, metaplastic carcinoma
Lobular stromaFibroadenoma; benign phyllodesNot applicableMalignant phyllodes tumour
Vessels and lymphoid tissueHaemangiomaNot applicableAngiosarcoma; lymphoma

Simplified from the WHO classification (5th edition). "Ductal" and "lobular" describe patterns, not the site of origin: both arise in the terminal duct lobular unit.